• In the United States for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.
• In Europe for electrocoagulation of soft tissues for vulvovaginal laxity.
Important Safety Considerations:
Thermi radiofrequency products should not be used on patients who are pregnant, have a fever or skin infection in or around the area of treatment. Expected procedure side effects may include transient pain in the procedure area, erythema and edema.
Individual results may vary. Models not actual patients.
© 2020 ThermiGen, LLC. All rights reserved.
The ARVATI device is intended to create lesions in nervous tissue and for use in dermatological and general surgical procedures for electrocoagulation and hemostasis.
©2022 ThermiGen, LLC. All rights reserved